DrosophilaModels of Tauopathies: What Have We Learned?
Author(s) -
Marc Gistelinck,
JeanCharles Lambert,
Patrick Callaerts,
Bart Dermaut,
Pierre Dourlen
Publication year - 2012
Publication title -
international journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.657
H-Index - 49
eISSN - 2090-8024
pISSN - 2090-0252
DOI - 10.1155/2012/970980
Subject(s) - frontotemporal dementia , neurotoxicity , neuroscience , drosophila (subgenus) , tau protein , disease , dementia , model organism , computational biology , tau pathology , medicine , biology , bioinformatics , genetics , alzheimer's disease , gene , pathology , toxicity
Aggregates of the microtubule-associated protein Tau are neuropathological hallmark lesions in Alzheimer's disease (AD) and related primary tauopathies. In addition, Tau is genetically implicated in a number of human neurodegenerative disorders including frontotemporal dementia (FTD) and Parkinson's disease (PD). The exact mechanism by which Tau exerts its neurotoxicity is incompletely understood. Here, we give an overview of how studies using the genetic model organism Drosophila over the past decade have contributed to the molecular understanding of Tau neurotoxicity. We compare the different available readouts for Tau neurotoxicity in flies and review the molecular pathways in which Tau has been implicated. Finally, we emphasize that the integration of genome-wide approaches in human or mice with high-throughput genetic validation in Drosophila is a fruitful approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom